World Journal of
Pharmaceutical and Life Sciences

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical and Life Sciences
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
World Journal of Pharmaceutical and Life Sciences (WJPLS) has indexed with various reputed international bodies like : Google Scholar, Index Copernicus, Scientific Indexing Services (SIS), Indian citation Index (ICI), Directory of Research Journals Indexing, Scintific journal impact factorScientific Journal Impact Factor (SJIF), Jour Informatics (Under Process), UDLedge Science Citation Index, Global Impact Factor (In Process), International Impact Factor Services, International Society for Research Activity (ISRA) Journal Impact Factor (JIF), Science Library Index, Dubai, United Arab Emirates, International Innovative Journal Impact Factor (IIJIF), Scientific Journal Impact Factor (SJIF), Eurasian Scientific Journal Index (ESJI), Cosmos Impact Factor, IFSIJ Measure of Journal Quality, International Scientific Indexing, UAE (ISI), Web of Science Group (Under Process), Research Bible, Fuchu, Tokyo. JAPAN, Scholar Article Journal Index (SAJI), Scope Database, Academia, 

Abstract

DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION OF NEW DRUG CANDIDATE AS A POTENTIAL MEMORY ENHANCER

Ishwari R. Chaudhari* (PhD Scholar), Dr. Deepak S. Mohale (PhD Supervisor) and Prof. Dr. Anil Chandewar (Principle)

ABSTRACT

? Introduction: Alzheimer's disease (AD) is a neurodegenerative disease of the brain associated with decrease of cognitive function, memory impairment, and behavioral changes. More than 25 million people in the world today are affected by dementia, most suffering from Alzheimer's disease. In both developed and developing nations, Alzheimer's disease has had tremendous impact on the affected individuals, caregivers, and society. The duration of the disease can vary between 5 years and 20 years. 5-hydroxytryptamine (5-HT, serotonin) is an important neurotransmitter in the modulation of the cognitive, behavioral and psychological functions in animals and humans. Among the fourteen subtypes of 5-HT receptor, 5-HT1A receptor has been extensively studied. An azapirone derivative with strong and selective agonist effect on 5-HT1A receptor, has been used for the treatment of anxiety disorders especially generalized Alzheimer's disease for decades. With the advances in studies of the pathogenic mechanisms in AD.The target of new AD drug development has been directed to modifying the pathology.
? Aim & Objective: To design and synthesize the new chemical entity as a new class of azapirone derivative.
? Method: Generated virtual library of compound having structural similarity with available entity then sort out promising compound from the generated library by virtual screening then select specific compounds by performed molecular docking of selected compounds form the library and see the desired interaction then performed molecular dynamics of specific molecules. Sorted final lead molecules showing desired properties and synthesized and characterization of final lead molecule and evaluated the Alzheimer activity.
? Results: azapirone derivative compounds shows significant effect on Alzheimer's disease.

[Full Text Article]   [Download Certificate]

WJPLS CITATION

  All Since 2020
 Citation  590  424
 h-index  12  10
 i10-index  17  14

INDEXING

NEWS & UPDATION

    A PHP Error was encountered

    Severity: Notice

    Message: Undefined variable: news

    Filename: views/right_panel.php

    Line Number: 79

    A PHP Error was encountered

    Severity: Warning

    Message: Invalid argument supplied for foreach()

    Filename: views/right_panel.php

    Line Number: 79

BEST ARTICLE AWARDS

World Journal of Pharmaceutical and life sciences is giving Best Article Award in every Issue for Best Article and Issue Certificate of Appreciation to the Authors to promote research activity of scholar.

Best Article of current issue

Download Article : Click here